BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 25, 2025

  April 28, 2025

   · 

  2 min read
• Press Releases

  Prelude Announces Presentations at 2025 AACR Annual Meeting

  April 28, 2025

   · 

  7 min read
• Press Releases

  Antengene Presents Four Posters at AACR 2025 Highlighting Focuses on AnTenGagerTM TCEs and Synthetic Lethality

  April 28, 2025

   · 

  10 min read
• Press Releases

  Protara Therapeutics Announces Positive Interim Results Demonstrating Durable Responses in the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC

  April 28, 2025

   · 

  8 min read
• Press Releases

  Polyrizon Reports Successful Safety Study of a Formulation of PL-14 Allergy Blocker in Human Nasal Tissue Model

  April 28, 2025

   · 

  4 min read
• Press Releases

  Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

  April 28, 2025

   · 

  1 min read
• Press Releases

  Lung Immune Cell Type “Quietly” Controls Inflammation in COVID-19

  April 28, 2025

   · 

  5 min read
• Press Releases

  Tevogen Bio Announces 2025 Annual Meeting

  April 28, 2025

   · 

  2 min read
• Press Releases

  UroGen Pharma Announces Encouraging Results from a Phase 1 Dose-Escalation Study Evaluating UGN-301 in Non-Muscle Invasive Bladder Cancer

  April 28, 2025

   · 

  8 min read
• Press Releases

  Johnson & Johnson’s TAR-200 monotherapy demonstrates highest complete response rate reported to date with sustained clinical benefits in patients with certain types of bladder cancer

  April 28, 2025

   · 

  11 min read